359 related articles for article (PubMed ID: 21979994)
1. Role of implantable cardioverter defibrillator therapy in patients with acquired long QT syndrome: a long-term follow-up.
Mönnig G; Köbe J; Löher A; Wasmer K; Milberg P; Zellerhoff S; Pott C; Zumhagen S; Radu R; Scheld HH; Haverkamp W; Schulze-Bahr E; Eckardt L
Europace; 2012 Mar; 14(3):396-401. PubMed ID: 21979994
[TBL] [Abstract][Full Text] [Related]
2. Implantable cardioverter-defibrillator therapy in patients with congenital long-QT syndrome: a long-term follow-up.
Mönnig G; Köbe J; Löher A; Eckardt L; Wedekind H; Scheld HH; Haverkamp W; Milberg P; Breithardt G; Schulze-Bahr E; Böcker D
Heart Rhythm; 2005 May; 2(5):497-504. PubMed ID: 15840474
[TBL] [Abstract][Full Text] [Related]
3. Congenital long QT 3 in the pediatric population.
Blaufox AD; Tristani-Firouzi M; Seslar S; Sanatani S; Trivedi B; Fischbach P; Paul T; Young ML; Tisma-Dupanovic S; Silva J; Cuneo B; Fournier A; Singh H; Tanel RE; Etheridge SP
Am J Cardiol; 2012 May; 109(10):1459-65. PubMed ID: 22360817
[TBL] [Abstract][Full Text] [Related]
4. Implantable cardioverter defibrillator therapy for prevention of sudden cardiac death in children in the Netherlands.
Heersche JH; Blom NA; van de Heuvel F; Blank C; Reimer AG; Clur SA; Witsenburg M; ten Harkel AD
Pacing Clin Electrophysiol; 2010 Feb; 33(2):179-85. PubMed ID: 20025697
[TBL] [Abstract][Full Text] [Related]
5. Who are the long-QT syndrome patients who receive an implantable cardioverter-defibrillator and what happens to them?: data from the European Long-QT Syndrome Implantable Cardioverter-Defibrillator (LQTS ICD) Registry.
Schwartz PJ; Spazzolini C; Priori SG; Crotti L; Vicentini A; Landolina M; Gasparini M; Wilde AA; Knops RE; Denjoy I; Toivonen L; Mönnig G; Al-Fayyadh M; Jordaens L; Borggrefe M; Holmgren C; Brugada P; De Roy L; Hohnloser SH; Brink PA
Circulation; 2010 Sep; 122(13):1272-82. PubMed ID: 20837891
[TBL] [Abstract][Full Text] [Related]
6. Long-term clinical outcome in patients with severe left ventricular dysfunction and an implantable cardioverter-defibrillator after ventricular tachyarrhythmias.
Pelicano N; Oliveira M; Da Silva N; Antunes E; Santos S; Conceição JM; Roquette J; Quininha J
Rev Port Cardiol; 2005 Apr; 24(4):487-98. PubMed ID: 15977773
[TBL] [Abstract][Full Text] [Related]
7. The ICD for primary prevention in patients with inherited cardiac diseases: indications, use, and outcome: a comparison with secondary prevention.
Olde Nordkamp LR; Wilde AA; Tijssen JG; Knops RE; van Dessel PF; de Groot JR
Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):91-100. PubMed ID: 23275262
[TBL] [Abstract][Full Text] [Related]
8. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
[TBL] [Abstract][Full Text] [Related]
9. Post-acute management of the acquired long QT syndrome.
Barra S; Agarwal S; Begley D; Providência R
Postgrad Med J; 2014 Jun; 90(1064):348-58. PubMed ID: 24696523
[TBL] [Abstract][Full Text] [Related]
10. Implantable cardioverter-defibrillator therapy in Brugada syndrome: a 20-year single-center experience.
Conte G; Sieira J; Ciconte G; de Asmundis C; Chierchia GB; Baltogiannis G; Di Giovanni G; La Meir M; Wellens F; Czapla J; Wauters K; Levinstein M; Saitoh Y; Irfan G; Julià J; Pappaert G; Brugada P
J Am Coll Cardiol; 2015 Mar; 65(9):879-88. PubMed ID: 25744005
[TBL] [Abstract][Full Text] [Related]
11. [The implantable cardioverter-defibrillator: the Portuguese experience].
Adragão P; Neves J; Sousa J; Fançoni J; da Silva N; Antunes E; Elvas L; Bernardo J
Rev Port Cardiol; 1997 Apr; 16(4):367-74, 351-2. PubMed ID: 9254126
[TBL] [Abstract][Full Text] [Related]
12. Implantable cardioverter-defibrillator explantation for overdiagnosed or overtreated congenital long QT syndrome.
Gaba P; Bos JM; Cannon BC; Cha YM; Friedman PA; Asirvatham SJ; Ackerman MJ
Heart Rhythm; 2016 Apr; 13(4):879-85. PubMed ID: 26681611
[TBL] [Abstract][Full Text] [Related]
13. Implantable cardioverter defibrillators in arrhythmogenic right ventricular dysplasia/cardiomyopathy: patient outcomes, incidence of appropriate and inappropriate interventions, and complications.
Schinkel AF
Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):562-8. PubMed ID: 23673907
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up of implantable cardioverter-defibrillator for secondary prevention in chagas' heart disease.
Martinelli M; de Siqueira SF; Sternick EB; Rassi A; Costa R; Ramires JA; Kalil Filho R
Am J Cardiol; 2012 Oct; 110(7):1040-5. PubMed ID: 22727179
[TBL] [Abstract][Full Text] [Related]
15. [Implantable cardioverter-defibrillator in the treatment of two patients with an increased risk of sudden cardiac death].
van den Berg MP; van Tintelen JP; van Dessel PF; van Veldhuisen DJ
Ned Tijdschr Geneeskd; 2004 Oct; 148(43):2132-5. PubMed ID: 15553359
[TBL] [Abstract][Full Text] [Related]
16. Primary prevention with the implantable cardioverter-defibrillator in high-risk long-QT syndrome patients.
Biton Y; Rosero S; Moss AJ; Goldenberg I; Kutyifa V; McNitt S; Polonsky B; Baman JR; Zareba W
Europace; 2019 Feb; 21(2):339-346. PubMed ID: 29947754
[TBL] [Abstract][Full Text] [Related]
17. Effect of concomitant antiarrhythmic therapy on survival in patients with implantable cardioverter defibrillators.
Ho AT; Pai SM; Timothy P; Pai RG
Pacing Clin Electrophysiol; 2005 Jul; 28(7):647-53. PubMed ID: 16008799
[TBL] [Abstract][Full Text] [Related]
18. Implantable cardioverter-defibrillators in patients with long QT syndrome: a multicentre study.
Zienciuk-Krajka A; Sterliński M; Filipecki A; Owczuk R; Bednarek J; Kempa M; Sielski S; Dziduszko M; Mitkowski P; Kaźmierczak J; Kuśnierz J; Michałkiewicz D; Stec SM; Gułaj M; Majcherek R; Lubiński A; Raczak G
Kardiol Pol; 2018; 76(12):1687-1696. PubMed ID: 30251242
[TBL] [Abstract][Full Text] [Related]
19. Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy.
Lin G; Nishimura RA; Gersh BJ; Phil D; Ommen SR; Ackerman MJ; Brady PA
Heart; 2009 May; 95(9):709-14. PubMed ID: 19282314
[TBL] [Abstract][Full Text] [Related]
20. Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study-part 2.
Sacher F; Probst V; Maury P; Babuty D; Mansourati J; Komatsu Y; Marquie C; Rosa A; Diallo A; Cassagneau R; Loizeau C; Martins R; Field ME; Derval N; Miyazaki S; Denis A; Nogami A; Ritter P; Gourraud JB; Ploux S; Rollin A; Zemmoura A; Lamaison D; Bordachar P; Pierre B; Jaïs P; Pasquié JL; Hocini M; Legal F; Defaye P; Boveda S; Iesaka Y; Mabo P; Haïssaguerre M
Circulation; 2013 Oct; 128(16):1739-47. PubMed ID: 23995538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
